drugset / Trial / NCT03422666

Plasma Lipoprotein Response to Glucagon-like Peptide-2

NCT03422666

Phase 2/3 Completed 10 enrolled University Health Network, Toronto
RandomizedCrossoverSingle-blindBasic science

Summary

Some of the fat (triglyceride) from the food humans eat gets stored in the bowel. This triglyceride can then be released into the blood when another meal is consumed or in response to hormones. How the gut hormone glucagon-like peptide-2 (GLP-2) releases the triglyceride from the gut is not known. The research team in this study is interested in finding out how teduglutide (a degradation resistant form of GLP-2) releases stored triglyceride from the gut by evaluating how blood lipoproteins respond to teduglutide in healthy individuals.

Timeline

Start
2018-09-21
Primary completion
2021-06-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Teduglutide Peptide 0.05 mg/kg Subcutaneous

Indications